• Monitoring and Management of CAR T-Cell Therapy Complications

  • May 11 2023
  • Length: 22 mins
  • Podcast

Monitoring and Management of CAR T-Cell Therapy Complications

Listen for free

View show details

  • Summary

  • Join Drs Amelia Langston and Jean Koff as they discuss the monitoring and management of complications before, during, and after CAR T therapy.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987066). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Cancer Immunotherapy With Chimeric Antigen Receptor (CAR) T Cells https://emedicine.medscape.com/article/2500108-overview

    Cytokine Release Syndrome https://emedicine.medscape.com/article/2500111-overview

    Immune Effector Cell Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor-T Cell Therapy https://pubmed.ncbi.nlm.nih.gov/36081506/

    On-target and Off-target-based Toxicologic Effects https://pubmed.ncbi.nlm.nih.gov/23085982/

    Cytokine https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytokine

    Tocilizumab (Rx) https://reference.medscape.com/drug/actemra-tocilizumab-999419

    CARTOX 10 Point Neurological Assessment https://reference.medscape.com/viewarticle/886616_5

    Levetiracetam https://www.ncbi.nlm.nih.gov/books/NBK499890/

    Cytopenia After CAR-T Cell Therapy-A Brief Review of a Complex Problem https://pubmed.ncbi.nlm.nih.gov/35326654/

    Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome https://pubmed.ncbi.nlm.nih.gov/36906275/

    Management of Hypogammaglobulinaemia and B-cell Aplasia https://www.ncbi.nlm.nih.gov/books/NBK584138/

    Rituximab (Rx) https://reference.medscape.com/drug/rituxan-truxima-rituximab-342243

    Bispecific Targeting of CD20 and CD19 Increases Polyfunctionality of Chimeric Antigen Receptor T-cell Products in B-cell Malignancies https://pubmed.ncbi.nlm.nih.gov/35597752/

    Mantle Cell Lymphoma https://www.ncbi.nlm.nih.gov/books/NBK536985/

    Chimeric Antigen Receptor (CAR) T-cell Treatment for Mantle Cell Lymphoma (MCL) https://pubmed.ncbi.nlm.nih.gov/35237395/

    Apheresis https://www.cancer.gov/publications/dictionaries/cancer-terms/def/apheresis
    Show More Show Less
Show More Show Less
activate_samplebutton_t1

What listeners say about Monitoring and Management of CAR T-Cell Therapy Complications

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.